The Lamy Co., Ltd. (KOSDAQ:032860)
1,414.00
-77.00 (-5.16%)
At close: Feb 27, 2026
The Lamy Market Cap
The Lamy has a market cap or net worth of 57.12 billion as of February 27, 2026. Its market cap has increased by 11.69% in one year.
Market Cap
57.12B
Enterprise Value
n/a
Revenue
63.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,414.00
Market Cap Chart
Since November 2, 2010, The Lamy's market cap has decreased from 128.64B to 57.12B, a decrease of -55.60%. That is a compound annual growth rate of -5.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 57.12B | 6.88% |
| Dec 30, 2025 | 53.44B | 10.53% |
| Dec 30, 2024 | 48.35B | -33.60% |
| Dec 30, 2021 | 72.81B | -10.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MinTech | 57.66B |
| FOODWELL | 57.61B |
| Korea Arlico Pharm | 57.40B |
| Milae Bioresources | 57.22B |
| HASS Corp. | 57.14B |
| Mercury | 56.90B |
| IGLOO | 56.90B |
| GFC Life Science | 56.85B |